Related Experiment Video
Updated: Jul 23, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes
D Goldberg1, D Panigrahi, M Barazi
1Department of Ophthalmology, The Georgetown University-Washington Hospital Center, Washington, DC, USA.
Purpose:
To report a case of rofecoxib (Vioxx)-associated Stevens-Johnson syndrome with corneal and conjunctival changes.
Design:
Interventional case report.
Methods:
Case report of a 62-year-old woman with systemic lupus erythematosus (SLE) taking rofecoxib for arthritis for 3 weeks.
Results:
Stevens-Johnson syndrome after 3 weeks of rofecoxib therapy.
Conclusion:
This case report suggests that oral rofecoxib may trigger Stevens-Johnson syndrome, potentially causing symblepharons, corneal neovascularization and cicatricial ectropions.
More Related Videos
06:15Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
04:48Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
Related Concept Videos
Allergic Drug Reactions
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Drug toxicity: Idiosyncratic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions